Active
Small Business
Overview
- Legal name
- PINE PHARMACEUTICALS LLC
- Registered location
- TONAWANDA, NY, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Aug 20, 2026
Read company summary
PINE PHARMACEUTICALS LLC is associated with UEI TCJXKNYD6WL5 and CAGE 7JZE9 in public federal records. AcornBids currently links 16 prime awards totaling $1.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing; Surgical and Medical Instrument Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists TONAWANDA, NY, USA.
At a glance
Lifetime prime obligations$1.2M
Prime awards16
Awards with future end dates5
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- PINE PHARMACEUTICALS LLC
- UEI
- TCJXKNYD6WL5
- CAGE
- 7JZE9
- Registered address
- 355 RIVERWALK PKWY, TONAWANDA, NY, 14150, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Sep 24, 2025
- Initial registration
- Feb 8, 2016
- Entity start
- Sep 1, 2014
- SAM updated
- Sep 24, 2025
- Registration expires
- Sep 22, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- NY, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N94021P00105PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE (POTASSIUM PALMITATE U-13C) FOR METABOLIC RESEARCH | Department of Health and Human Services | $41.5K | Jan 5, 2021 | Aug 20, 2027 |
| 75N98026F00003NIDDK: STABLE ISOTOPES DEUTERIUM OXIDE (D, 70%), GLYCEROL (D5 GLYCEROL), AND GLUCOSE (6,6 DEUTERATED GLUCOSE) | Department of Health and Human Services | $410.8K | Jul 8, 2026 | Sep 30, 2026 |
| 75N98026F00002NIDDK METABOLIC ISOTOPES | Department of Health and Human Services | $54.5K | Sep 30, 2024 | Sep 29, 2029 |
| 36C26326N0200503B COMPOUNDING PHARMACEUTICALS | Department of Veterans Affairs | $21.7K | Oct 1, 2025 | Mar 31, 2026 |
| 75N98026F000011. 26-003399 - IDIQ 75N94024D00003, SEND PO TO AGENTILE@PINEPHARMACEUTICALS.COM, DELIVERY BY 6/1/26; ORAL STABLE ISOTOPE-DEUTERIUM OXIDE, BILLING IN ONE LUMP SUM, NIH POC… | Department of Health and Human Services | $39.3K | Apr 21, 2026 | Oct 30, 2026 |
| 75N90020P00581STORAGE AND STABILITY TESTING BY PINE PHARMACEUTICALS, LLC:1270808 [POTS: 20-011114] | Department of Health and Human Services | $9.0K | Sep 9, 2020 | Sep 8, 2024 |
| 75N98C26P00019ATORVASTATIN 40 MG CAPSULES AND PLACEBO CAPSULES, QTY 1,232 BATCH. | Department of Health and Human Services | $24.7K | Feb 17, 2026 | Feb 16, 2027 |
| 36C26325N0138503B COMPOUNDING PHARMACEUTICALS | Department of Veterans Affairs | $37.7K | Oct 1, 2024 | Sep 30, 2025 |
| 75N94025F00003NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE | Department of Health and Human Services | $69.5K | Aug 14, 2025 | May 31, 2026 |
| 75N94026F00001NIDDK: PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE. | Department of Health and Human Services | $91.9K | Dec 18, 2025 | May 31, 2026 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Sep 24, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Feb 8, 2016 |
| Entity start | Sep 1, 2014 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ALFONSE J MUTO | Government business | Contact method not published | SAM registration | Not available |
| ALLISON GENTILE | Alternate government business | Contact method not published | SAM registration | Not available |
| ALFONSE J MUTO | Electronic business | Contact method not published | SAM registration | Not available |
| ALLISON GENTILE | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
291 awards
65 awards
54 awards
46 awards
44 awards
38 awards
33 awards
24 awards
About PINE PHARMACEUTICALS LLC
What products and services appear in its federal awards?
Recorded award industries: 325412 — Pharmaceutical Preparation Manufacturing; 339112 — Surgical and Medical Instrument Manufacturing.
Recorded products and services: 6505 — Drugs and Biologicals; 6640 — Laboratory Equipment and Supplies; B504 — Chemical/Biological Studies and Analysis.
Examples from recent award records:
- PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE (POTASSIUM PALMITATE U-13C) FOR METABOLIC RESEARCH
- NIDDK: STABLE ISOTOPES DEUTERIUM OXIDE (D, 70%), GLYCEROL (D5 GLYCEROL), AND GLUCOSE (6,6 DEUTERATED GLUCOSE)
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
355 RIVERWALK PKWY, TONAWANDA, New York 14150, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Veterans Affairs.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit